No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
MYX Mayne Pharma Group Ltd
- 4.900
- +0.010+0.20%
20min DelayMarket Closed Dec 17 16:00 AET
398.10MMarket Cap-2.24P/E (Static)
4.920High4.850Low41.76KVolume4.880Open4.890Pre Close204.56KTurnover7.46052wk High0.07%Turnover Ratio81.25MShares3.74052wk Low-2.19EPS TTM297.82MFloat Cap31.320Historical HighLossP/E (Static)60.78MShs Float-10.006Historical Low-2.19EPS LYR1.43%Amplitude--Dividend TTM0.88P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Mayne Pharma Confirms Financial Adviser Appointment for Strategic Review
Shareholders in Mayne Pharma Group (ASX:MYX) Are in the Red If They Invested Five Years Ago
Mayne Pharma Target Price Cut 16% to A$5.93/Share by Wilsons>MYX.AU
Mayne Pharma Price Target Cut 6.6% to A$6.25/Share by Canaccord Genuity
Why Bank of Queensland, Fisher & Paykel, Mayne Pharma, and Medibank Shares Are Rising
3 ASX Healthcare Stocks Surging After Strong FY24 Earnings
Trending AU Stocks
ASX High Dividend ASX High Dividend